Business Description
Inmolecule Nanotech SA
ISIN : ES0105908000
Compare
Compare
Traded in other countries / regions
MLINA.FranceDC0.Germany IPO Date
2025-08-18Description
Inmolecule Nanotech SA is a research and development company. The company provides health care, home care and personal care products.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.26 | |||||
Debt-to-EBITDA | 52.51 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 100 | |||||
14-Day RSI | 100 | |||||
3-1 Month Momentum % | 2.51 | |||||
6-1 Month Momentum % | 2.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.09 | |||||
Quick Ratio | 1.25 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 2372.5 | |||||
Days Sales Outstanding | 307.33 | |||||
Days Payable | 733.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 79.86 | |||||
Operating Margin % | -11.01 | |||||
Net Margin % | -11.51 | |||||
EBITDA Margin % | 1.87 | |||||
ROE % | -2.86 | |||||
ROA % | -1.71 | |||||
ROIC % | -2.01 | |||||
ROC (Joel Greenblatt) % | -6.46 | |||||
ROCE % | -2.1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 15.45 | |||||
PB Ratio | 4.14 | |||||
Price-to-Tangible-Book | 18.55 | |||||
EV-to-EBIT | -149.86 | |||||
EV-to-EBITDA | 878.89 | |||||
EV-to-Revenue | 16.42 | |||||
| Price-to-Net-Current-Asset-Value | 25.5 | |||||
Earnings Yield (Greenblatt) % | -0.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Inmolecule Nanotech SA Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.981 | ||
| EPS (TTM) (€) | -0.03 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 100 | ||
| 14-Day ATR (€) | 0.001398 | ||
| 20-Day SMA (€) | 4.08 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 3.98 - 4.08 | ||
| Shares Outstanding (Mil) | 7.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inmolecule Nanotech SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inmolecule Nanotech SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Inmolecule Nanotech SA Frequently Asked Questions
What is Inmolecule Nanotech SA(XPAR:MLINA)'s stock price today?
The current price of XPAR:MLINA is €4.08. The 52 week high of XPAR:MLINA is €4.08 and 52 week low is €3.98.
When is next earnings date of Inmolecule Nanotech SA(XPAR:MLINA)?
The next earnings date of Inmolecule Nanotech SA(XPAR:MLINA) is .
Does Inmolecule Nanotech SA(XPAR:MLINA) pay dividends? If so, how much?
Inmolecule Nanotech SA(XPAR:MLINA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Inmolecule Nanotech SA
No articles.